相关实验视频
Updated: Sep 14, 2025

10:20
In vitro Measurements of Tracheal Constriction Using Mice
Published on: June 25, 2012
20.9K
药理学Gq准阻止了喘性气道改造
Jennifer M Dietrich1, Michaela Matthey2, Annika Simon2
1Institute of Physiology I, Life&Brain Center, Medical Faculty, University of Bonn, 53127 Bonn, Germany.
概括
在喘模型中,用FR900359 (FR) 对Gq信号的药理抑制有效地减少了气道重塑. 这种方法针对像原沉积和粘液过度产生的关键特征,提供了一个有前途的喘治疗策略.
科学领域:
- 肺部医学 肺部医学
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 气道重塑,以原沉积和杯状细胞转化为特征,是慢性喘难以治疗的标志.
- Gq信号通路与喘和呼吸道重塑的病原发生有关.
研究的目的:
- 调查Gq信号在气道改造中的作用.
- 在喘模型中评估Gq抑制剂FR900359 (FR) 的治疗潜力.
主要方法:
- 在小鼠中使用了慢性卵泡胺诱导的喘模型.
- 评估了FR对原沉积和杯状细胞代谢的影响.
- 研究了FR对人类肺纤维细胞生长,粘液生产和分泌物的影响,在体外和人类肺部切片中.
主要成果:
- 在小鼠喘模型中,FR局部应用显著减弱了原沉积和杯状细胞代谢.
- 在对病理性刺激的反应中,FR减轻了人类肺纤维细胞的增殖.
- 在各种人类细胞培养模型中,FR抑制了粘液的产生和分泌,包括喘肺切片.
结论:
- Gq蛋白质在推动喘中的呼吸道重塑过程中发挥着关键作用.
- 通过FR传递Gq信号的药理抑制是治疗慢性喘的一个有希望的治疗策略.
相关概念视频
Antiasthma Drugs: Leukotriene Modifiers
482
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
482
Asthma: Pathogenesis and Management
597
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
597
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
464
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
464
Antiasthma Drugs: Muscarinic Receptor Antagonists
463
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
463
Antiasthma Drugs: β2-Adrenoceptor Agonists
389
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
389
Antiasthma Drugs: Methylxanthines
408
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
408

